FDA Publishes Guidance for Expedited Review of Device Premarket Submissions

Summary

The Food and Drug Administration (FDA) has released a new guidance document outlining its procedures for expedited review of premarket submissions for medical devices, including 510(k)s, product development protocols, and de novo classification actions.